跳至主要内容
临床试验/NCT00279006
NCT00279006Unknown不适用

Adhesiveness of Coronary Drug-Eluting Stents to the Delivery Balloon-Catheter: A Randomized Comparison

Foundation for Cardiovascular Research, Zurich0 个研究点目标入组 150 人开始时间: 2006年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
150
主要终点
In-Hospital mortality, myocardial infarction, or need for unplanned urgent repeat revascularization.

研究概览

简要总结

This study will evaluate the 3 drug-eluting stents presently marketed for intervention in the coronary artery with respect to the complications that may occur in case it becomes necessary to retract the stent during the intervention. It has been noted that stents carrying a drug for local application may be more difficult to retract than the more smooth bare metal stents.

详细描述

Patients in whom DES implantation is planned will be randomized to one of the 3 commercially available stents (i.e., Cypher, Taxus-Liberté, Endeavor).

Sealed envelopes will be used for randomization purposes. Should additional stents be required in the same patient for the same or other lesions, another stent of the same type of stents will be implanted.

The following assessments will be made:

  • Unblinded subjective operator assessment based on a questionnaire. The questionnaire will include questions on problems encountered during stent-balloon retrieval, special maneuvers performed (e.g., retrieval of the catheter during device removal, and possible complications associated with device retrieval).
  • Blinded measurements of following parameters:
  1. Minimal and maximal distance between the tip of the guiding catheter and the proximal stent end during stent-balloon retrieval.
  2. Minimal and maximal distance between the tip of the guidewire and the distal portion of the stent during stent-balloon retrieval.
  3. To do so the retrieval of the stent-balloon will be documented on ciné-angiography. The measurements will be performed by a qualified technician/physician blinded to the type of device used.
  • Clinical endpoints:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with a planned angiography and percutane coronary intervention
  • Age 18 years or above
  • Informed consent to PCI and to participation in this trial

排除标准

  • Patients who after angiography are deemed not suitable for stent implant (operators discretion)

结局指标

主要结局

In-Hospital mortality, myocardial infarction, or need for unplanned urgent repeat revascularization.

Myocardial infarction defined as creatine kinase MB-isoform [CK-MB] ≥3x upper limit of normal within 24 hours of the procedure or ≥2x upper limit of normal after 24 hours of the procedure in the presence of new ischemic symptoms.

次要结局

未报告次要终点

研究者

发起方
Foundation for Cardiovascular Research, Zurich
申办方类型
Other

相似试验